Anthony Mancini Sells 1,774 RVMD Shares at $199.30, Totaling $353,449

On September 20, 2026, Anthony Mancini, an insider of Revolution Medicines, Inc. (RVMD), sold 1,774 shares at $199.30 each, totaling $353,449.

Who is Anthony Mancini and what is his real role at Revolution Medicines, Inc.?

The form indicates "See Remarks" for the position held, meaning the exact role is not detailed in the public document. In practice, anyone listed as an insider has direct or indirect access to non-public information, whether as a director, board member, or senior official. This position grants knowledge of strategic projects, upcoming financial results, or regulatory changes before they are publicly disclosed.

Because this information can influence stock prices, U.S. regulations require insiders to report every transaction in their company's securities. The declaration must be filed with the SEC's EDGAR system within two business days of the transaction to ensure transparency and limit market abuses. This obligation applies to all directors, administrators, and employees holding more than 10% of shares or exercising a decision-making role.

Transaction Details: 1,774 shares at $199.30 each

On September 20, 2026, the sale involved exactly 1,774 shares of Revolution Medicines, Inc. The per-share price was $199.30, resulting in a total transaction value of $353,449. It is important to distinguish clearly between the per-share price ($199.30) and the total value ($353,449), two distinct figures appearing in the Form 4.

The form does not specify whether the transaction was executed on the secondary market or through a private agreement, but the total amount indicates a notable transaction for an individual insider. Without knowing the number of shares previously held, it is impossible to quantify the portion sold, but the volume far exceeds the small sales of just dozens of shares sometimes observed.

Why Insiders Sell Their Shares — Possible Reasons

A share sale can result from several legitimate motivations. Portfolio diversification is a common reason: an insider may reduce their exposure to a single company to balance overall risk. Tax planning can also be a factor, particularly when a taxpayer seeks to realize capital gains or offset previous losses. Personal liquidity needs, such as financing real estate projects or paying taxes, may push to convert shares into cash.

In some cases, the sale reflects an anticipation of less favorable performance, creating a bearish signal for the market. However, the decision to sell should not be interpreted as certainty regarding the future direction of the stock price, as personal or financial reasons may override purely fundamental analysis.

How Individual Investors Follow Form 4 Filings

Form 4s are freely accessible on the SEC's EDGAR website, where each filing is indexed by the company name, ticker, and insider's name. Many online services aggregate this data and offer email or RSS feeds as new declarations are published. Platforms like OpenInsider, WhaleWisdom, or the "Insider Transactions" sections of Bloomberg allow filtering sales and purchases by amount, date, or type of insider.

Despite the availability of this information, investors must keep in mind its limitations: the form does not reveal the reasoning behind the transaction or the percentage of the portfolio involved. Prudent analysis therefore combines insider data with company fundamentals, sector trends, and technical indicators before making an investment decision.